862874-11-1 Usage
Molecular structure
1-Piperidinecarboxylic acid, 4-(5-chloro-4-methyl-2-nitrophenoxy)-, 1,1-dimethylethyl ester is a complex organic molecule that consists of a piperidine ring, a phenyl ring, and various substituents.
Derivative of piperidine
The compound is a derivative of piperidine, a heterocyclic amine, which means that it is a modified version of the parent compound.
Nitro and chlorine substituents
The compound contains a nitro group (-NO2) and a chlorine substituent (-Cl) on the phenyl ring, which can affect its chemical properties and reactivity.
1,1-dimethylethyl ester group
The addition of the 1,1-dimethylethyl ester group increases the compound's stability and lipophilicity, which can improve its absorption and distribution in the body.
Pharmaceutical use
The compound is used as an intermediate in the synthesis of various drugs in the pharmaceutical industry.
Therapeutic applications
The compound is utilized in the production of medications for various therapeutic applications, including cardiovascular, central nervous system, and metabolic disorders.
Role in pharmaceutical development
Due to its specific chemical structure and properties, the compound plays a crucial role in the development of new pharmaceutical products.
Check Digit Verification of cas no
The CAS Registry Mumber 862874-11-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,8,7 and 4 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 862874-11:
(8*8)+(7*6)+(6*2)+(5*8)+(4*7)+(3*4)+(2*1)+(1*1)=201
201 % 10 = 1
So 862874-11-1 is a valid CAS Registry Number.
862874-11-1Relevant academic research and scientific papers
BISARYLUREA DERIVATIVES
-
Page/Page column 188, (2010/02/13)
The present invention relates to bisarylurea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
SEMICARBAZIDE DERIVATIVES AS KINASE INHIBITORS
-
Page/Page column 214, (2008/06/13)
The present invention relates to semicarbazide derivatives of formula I, the use of the compounds of formula I as inhibitors of one or more kinases, the use of the compounds of formula I for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
